IP Landscape – mRNA Characterization
A leading global biopharma company sought a comprehensive IP landscape review to identify market gaps and enhance its competitive edge. Stellarix’s consulting insights helped the client expand into new markets and strategically position their IP portfolio by highlighting high-value technologies and untapped areas for patent filing. Client Background: A global biopharma leader focused on immune […]
Advanced Therapeutics Hub: Strategic Intelligence for Next-Generation Biopharma
Executive Summary: The Frontier of Next-Generation Medicines The worldwide healthcare and life science industry is changing its structure fundamentally. Traditional small-molecule drugs and standard biologics are being supplemented and, in some instances, replaced by advanced therapeutics that mend the damage at genetic, cellular, and molecular levels. The transformation to the future of healthcare is largely […]
Endosomal Escape: Unlocking Critical Hurdles of Intracellular Delivery
How Endosomal Escape Determines Success in Modern Medicine The “Endosomal trap” is responsible for eliminating 90–99% of the administered vaccine dose, resulting in low therapeutic potency, dose inefficiency, and limited clinical translation. When nanoparticles, viral vectors, and lipid carriers are taken into membrane-bound endosomes, these are sent to lysosomal degradation if the therapeutic cargo does […]
Identifying Growth Pathways to Navigate the Competitive Biosimilar Landscape
Client Background: The client is a leading global biopharmaceutical player seeking a structured assessment of competitor portfolios, manufacturing capabilities, pricing approaches, and emerging opportunities to guide long-term business strategies. Challenges: Engagement Objective: The engagement aimed to deliver an in-depth analysis of the biosimilar competitive landscape, identify competitive advantage, emerging opportunities, and strategic growth pathways to […]
Technology Landscape – Biodegradable Capsule Suspension
A renowned C&M industry client engaged Stellairx to assess the global technology landscape for bio-based encapsulation to determine potential market opportunities and reinforce its market position. The insights provided by our chemical consulting team helped the client devise a strategic roadmap for future collaboration and market entry, thereby enhancing business resilience. Client Background: A global […]
Protein Corona: The Unseen Force Shaping the Future of Nanomedicine
Unraveling the Mechanistic Blueprint of Protein Corona Formation Nanoparticles are transforming therapeutic and diagnostic methods, but their biological behavior remains largely dependent on the protein corona, i.e., the dynamic layer of proteins and biomolecules that adsorb to their surfaces shortly after exposure to a physiological environment. This protein corona, in turn, changes the nanoparticle’s identity, […]
Navigating Global Regulatory Challenges in Pharma: 2025 and Beyond
The pharmaceutical industry is one of the most regulated industries in the world. The regulatory environment is changing rapidly as we approach 2026 due to progress in drug development, changes in digital health technologies, and other implications of geopolitical changes. Companies must deal with intricate compliance obligations, global interoperability, and emerging trends in their regulated […]
Pharma’s Eco Pill- Sustainable Packaging
Given the growing environmental issues, the pharmaceutical industry is facing increasing pressure to implement sustainable practices. One major area of emphasis is packaging. Most conventional medicinal packaging has been deemed incongruous due to environmental concerns, including its high plastic content and use of non-recyclable materials. The management of packaging waste is now one of the […]
In-Vivo CAR-T Cell Therapy: The Next Chapter in Oncology
Cell Therapy: Cancer’s New Arsenal Though several therapeutic, biotech, and medtech developments are changing the oncology landscape, in-vivo CAR-T cell therapy stands out for its precision, accessibility, and upscaling capabilities. A step up from ex vivo CAR-T cell therapy, it takes precedence due to its improved toxicity management, manufacturing parameters, and broader scope of clinical […]
In-vivo CAR-T Cell Therapy: New Frontier in Cancer Treatment
Chimeric antigen receptor T-cell (CAR-T) therapy transformed oncology by paving the path for harnessing patients’ own cells to treat B-cell lymphomas, leukemias, and other hematological malignancies. Traditionally, CAR-T cell therapy for cancer relied on ex vivo processes, where a patient’s T-cells are extracted, genetically reprogrammed in an external medium to express synthetic receptors targeting cancer […]